Basic Information
| RNALocate ID: | RLID:01002574 |
| RNA Symbol: | hsa-miR-28-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-28-3p |
| RNA ID: | miRBase:MIMAT0004502 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 21637849 |
| Tissue/Cell Line: | Skeletal muscle myoblasts |
| Method: | ISH|qRT-PCR |
| Description: | List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002575 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002576 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11003598 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003599 | Exosome | Plasma | 23663360 |
| RLID:11003600 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11003601 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000179 | Exosome | Blood|Breast milk|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000582 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-28-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-34001 |
| MNDR | hsa-miR-28-3p | Lymphoma | MNDR-E-MI-34002 |
| MNDR | hsa-miR-28-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-34003 |
| MNDR | hsa-miR-28-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-34004 |
| MNDR | hsa-miR-28-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-34005 |
| MNDR | hsa-miR-28-3p | Her2-receptor positive breast cancer | MNDR-E-MI-34006 |
| MNDR | hsa-miR-28-3p | Breast cancer luminal | MNDR-E-MI-34007 |
| MNDR | hsa-miR-28-3p | Prostate cancer | MNDR-E-MI-34008 |
| MNDR | hsa-miR-28-3p | Gastric cancer | MNDR-E-MI-34009 |
| MNDR | hsa-miR-28-3p | Alzheimer disease | MNDR-E-MI-34010 |
| MNDR | hsa-miR-28-3p | Intracranial aneurysm | MNDR-E-MI-34011 |
| MNDR | hsa-miR-28-3p | Bladder cancer | MNDR-E-MI-34012 |
| MNDR | hsa-miR-28-3p | Esophageal carcinoma | MNDR-E-MI-34013 |
| MNDR | hsa-miR-28-3p | Dysautonomia familial | MNDR-E-MI-34014 |
| MNDR | hsa-miR-28-3p | Huntington disease | MNDR-E-MI-34015 |
| MNDR | hsa-miR-28-3p | Cardiovascular disease | MNDR-E-MI-34016 |
| MNDR | hsa-miR-28-3p | Lung cancer | MNDR-E-MI-34017 |
| MNDR | hsa-miR-28-3p | Parkinson disease | MNDR-E-MI-34018 |
| MNDR | hsa-miR-28-3p | Breast cancer | MNDR-E-MI-34019 |
| MNDR | hsa-miR-28-3p | Neuroendocrine neoplasia | MNDR-E-MI-34020 |
| MNDR | hsa-miR-28-3p | Pancreatic cancer | MNDR-E-MI-34021 |
| MNDR | hsa-miR-28-3p | Rectum adenocarcinoma | MNDR-E-MI-34022 |
| MNDR | hsa-miR-28-3p | Nephroblastoma | MNDR-E-MI-34023 |
| MNDR | hsa-miR-28-3p | Colon cancer | MNDR-E-MI-34024 |
| MNDR | hsa-miR-28-3p | Ischemic attack transient | MNDR-E-MI-34025 |
| MNDR | hsa-miR-28-3p | Colon adenocarcinoma | MNDR-E-MI-34026 |
| MNDR | hsa-miR-28-3p | Carcinoma ductal breast | MNDR-E-MI-34027 |
| MNDR | hsa-miR-28-3p | Glioblastoma | MNDR-E-MI-34028 |
| MNDR | hsa-miR-28-3p | Malignant glioma | MNDR-E-MI-34029 |
| MNDR | hsa-miR-28-3p | Chordoma | MNDR-E-MI-34030 |
| MNDR | hsa-miR-28-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-34031 |
| MNDR | hsa-miR-28-3p | Osteosarcoma | MNDR-E-MI-34032 |
| MNDR | hsa-miR-28-3p | Middle cerebral artery infarction | MNDR-E-MI-34033 |
| MNDR | hsa-miR-28-3p | Gastric adenocarcinoma | MNDR-E-MI-34034 |
| MNDR | hsa-miR-28-3p | Cervical squamous cell carcinoma | MNDR-E-MI-34035 |
| MNDR | hsa-miR-28-3p | Lung squamous cell carcinoma | MNDR-E-MI-34036 |
| MNDR | hsa-miR-28-3p | Lung adenocarcinoma | MNDR-E-MI-34037 |
| MNDR | hsa-miR-28-3p | Thyroid carcinoma | MNDR-E-MI-34038 |
| MNDR | hsa-miR-28-3p | Bladder urothelial carcinoma | MNDR-E-MI-34039 |
| MNDR | hsa-miR-28-3p | Pancreatic adenocarcinoma | MNDR-E-MI-34040 |
| MNDR | hsa-miR-28-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-34041 |
| MNDR | hsa-miR-28-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-34042 |
| MNDR | hsa-miR-28-3p | Renal clear cell carcinoma | MNDR-E-MI-34043 |
| MNDR | hsa-miR-28-3p | Cholangiocarcinoma | MNDR-E-MI-34044 |
| MNDR | hsa-miR-28-3p | Esophageal cancer | MNDR-E-MI-34045 |
| MNDR | hsa-miR-28-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-34046 |
| MNDR | hsa-miR-28-3p | Breast invasive carcinoma | MNDR-E-MI-34047 |
| MNDR | hsa-miR-28-3p | Hepatocellular carcinoma | MNDR-E-MI-34048 |
| MNDR | hsa-miR-28-3p | Rheumatoid arthritis | MNDR-E-MI-34049 |
| MNDR | hsa-miR-28-3p | Neuromyelitis optica | MNDR-E-MI-34050 |
| MNDR | hsa-miR-28-3p | Colorectal cancer | MNDR-E-MI-34051 |
| MNDR | hsa-miR-28-3p | Nasopharynx carcinoma | MNDR-E-MI-34052 |
| MNDR | hsa-miR-28-3p | Multiple myeloma | MNDR-E-MI-34053 |
| MNDR | hsa-miR-28-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-34054 |
| MNDR | hsa-miR-28-3p | Nasopharyngeal cancer | MNDR-E-MI-34055 |
| MNDR | hsa-miR-28-3p | Epstein-barr virus infections | MNDR-E-MI-34056 |
| MNDR | hsa-miR-28-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-34057 |
| MNDR | hsa-miR-28-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-34058 |
| MNDR | hsa-miR-28-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-34059 |
| MNDR | hsa-miR-28-3p | Peripheral nerve injuries | MNDR-E-MI-34060 |
| MNDR | hsa-miR-28-3p | Chronic pain | MNDR-E-MI-34061 |
| MNDR | hsa-miR-28-3p | Breast cancer her3+ negative | MNDR-E-MI-34062 |
| MNDR | hsa-miR-28-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-34063 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | LINC02381 | Homo sapiens | RR00849535 |
TOP